This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.
Clinical trial NCT05486975 · UNKNOWN
Trial details
- NCT number
- NCT05486975
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2025-01-29
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.